MoonLake Immunotherapeutics(MLTX)
Biotechnology
Cell Therapy (CAR-T, etc.)
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-23 | Reich Kristian Chief Scientific Officer | Sale | -52,448 | -1.85%2,782,505 | $20.02 | $1,049,960 | View SEC filing | |
| 2026-07-21 | Reich Kristian Chief Scientific Officer | Sale | -43,700 | -1.52%2,834,953 | $20.09 | $877,933 | View SEC filing | |
| 2026-07-20 | Reich Kristian Chief Scientific Officer | Sale | -16,105 | -0.56%2,878,653 | $20.01 | $322,261 | View SEC filing | |
| 2026-07-13 | Santos da Silva Jorge Chief Executive Officer | Sale | -102,225 | -3.38%2,924,893 | $20.02 | $2,046,205 | View SEC filing | |
| 2026-07-02 | Santos da Silva Jorge Chief Executive Officer | Sale | -47,775 | -1.55%3,027,118 | $20.03 | $956,933 | View SEC filing | |
| 2026-06-23 | Bodenstedt Matthias Chief Financial Officer | Sale | -39,120 | -3.14%1,205,656 | $22.04 | $862,205 | View SEC filing | |
| 2026-06-18 | Bodenstedt Matthias Chief Financial Officer | Sale | -17,876 | -1.42%1,244,776 | $19.67 | $351,576 | View SEC filing | |
| 2026-06-17 | Reich Kristian Chief Scientific Officer | Sale | -150,000 | -4.93%2,894,758 | $19.01 | $2,851,000 | View SEC filing | |
| 2026-05-13 | Bodenstedt Matthias Chief Financial Officer | Sale | -13,653 | -1.07%1,262,652 | $20.02 | $273,333 | View SEC filing | |
| 2026-04-16 | Bodenstedt Matthias Chief Financial Officer | Sale | -2,426 | -0.20%1,186,084 | $19.56 | $47,453 | View SEC filing | |
| 2026-04-14 | Santos da Silva Jorge Chief Executive Officer | Sale | -150,000 | -4.88%2,924,893 | $18.35 | $2,752,163 | View SEC filing | |
| 2026-04-10 | Bodenstedt Matthias Chief Financial Officer | Sale | -87,795 | -6.88%1,188,510 | $18.95 | $1,663,935 | View SEC filing | |
| 2026-04-02 | BIOTECHNOLOGY VALUE FUND L P Director, 10% Owner | Sale | -3,750,000 | -89.85%1,039,238 | $16.79 | $62,962,500 | View SEC filing | |
| 2025-12-10 | Santos da Silva Jorge Chief Executive Officer | Sale | -200,000 | -6.06%3,101,787 | $14.87 | $2,974,700 | View SEC filing | |
| 2025-12-10 | Reich Kristian Chief Scientific Officer | Sale | -202,908 | -6.31%3,010,992 | $14.85 | $3,012,462 | View SEC filing | |
| 2025-10-09 | Bodenstedt Matthias Chief Financial Officer | Purchase | +10,870 | +1.18%930,763 | $9.09 | $98,808 | View SEC filing | |
| 2025-10-01 | Cormorant Asset Management, LP Other | Sale | -6,499,978 | -76.52%1,994,173 | $7.21 | $46,868,184 | View SEC filing | |
| 2025-07-07 | Moukheibir Catherine Director | Sale | -23,500 | -100.00%0 | $48.79 | $1,146,565 | View SEC filing | |
| 2024-10-08 | Sturge Simon Director | Sale | -171,000 | -49.86%171,980 | $53.72 | $9,186,120 | View SEC filing | |
| 2024-10-08 | BIOTECHNOLOGY VALUE FUND L P Director, 10% Owner | Sale | -2,000,000 | -88.57%1,287,768 | $50.00 | $100,003,200 | View SEC filing | |
| 2024-02-29 | Santos da Silva Jorge Chief Executive Officer | Sale | -123,615 | -3.71%3,206,024 | $55.03 | $6,803,044 | View SEC filing | |
| 2024-02-29 | Reich Kristian Chief Scientific Officer | Sale | -118,922 | -3.62%3,169,706 | $55.00 | $6,540,710 | View SEC filing | |
| 2024-02-23 | Santos da Silva Jorge Chief Executive Officer | Sale | -1,125 | -0.03%3,329,639 | $55.27 | $62,179 | View SEC filing | |
| 2024-02-22 | Reich Kristian Chief Scientific Officer | Sale | -21,078 | -0.64%3,288,628 | $57.33 | $1,208,418 | View SEC filing | |
| 2024-02-20 | Santos da Silva Jorge Chief Executive Officer | Sale | -60,000 | -1.77%3,330,764 | $59.26 | $3,555,400 | View SEC filing |
1-25 of 35